NGMDF OTC
NuGen Medical Devices Inc.
1W: +0.0%
1M: +0.0%
3M: -39.3%
YTD: -62.0%
1Y: -76.2%
3Y: -93.3%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+204.7% ▲
Gross Profit
$522K
+216.6% ▲
Operating Income
-$5M
+35.9% ▲
Net Income
-$5M
+44.2% ▲
EPS (Diluted)
$-0.02
+56.3% ▲
EBITDA
-$3M
+60.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $47K | $138K | $152K | $331K | $1M |
| YoY Growth | +0.0% | +191.0% | +10.7% | +117.5% | +204.7% |
| Cost of Revenue | $13K | $45K | $706K | $167K | $488K |
| Gross Profit | $34K | $92K | -$553K | $165K | $522K |
| Gross Margin | 72.7% | 67.0% | -363.1% | 49.7% | 51.7% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3M | $8M | $4M | $8M | $5M |
| Operating Expenses | $3M | $8M | $4M | $8M | $6M |
| Operating Income | -$3M | -$8M | -$5M | -$8M | -$5M |
| Operating Margin | -5521.0% | -5573.1% | -3146.6% | -2428.5% | -510.7% |
| Interest Expense | $672K | $1M | $1M | $1M | $2M |
| Income Before Tax | -$4M | -$7M | -$6M | -$9M | -$5M |
| Tax Expense | $12K | $3K | $3K | $34K | $7K |
| Net Income | -$4M | -$7M | -$6M | -$9M | -$5M |
| Net Margin | -7760.7% | -5163.2% | -3661.1% | -2825.0% | -517.5% |
| EPS (Diluted) | $-0.14 | $-0.10 | $-0.06 | $-0.06 | $-0.02 |
| EBITDA | -$2M | -$5M | -$4M | -$7M | -$3M |
| Shares Outstanding | 27M | 69M | 90M | 168M | 214M |